July 2, 2024 July 2, 2024Categories New TrialsNow Enrolling: This myeloMATCH trial is testing a new treatment for patients with acute myeloid leukemia that has a FLT3-ITD or D835 mutationThis study compares a standard initial treatment with a new approach that has the potential to put more patients into remission
